Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAME: Novel Interventions for Malnutrition Enteropathy
NCT03716115Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of colostrum, n-acetyl-d-glucosamine, teduglutide, EPI-EE in severe acute malnutrition (SAM), environmental enteric dysfunction (EED), sponsored by Queen Mary University of London. Started May 2020; status: completed.
02
Drugs
colostrumn-acetyl-d-glucosamineteduglutideEPI-EE
03
Conditions
severe acute malnutrition (SAM)environmental enteric dysfunction (EED)
Beyond the preview
Go deeper on NCT03716115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03716115.